Regulatory News:
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half 2024: €2,772
million (up 9.2%)
- Strong revenue in all geographical areas, driven, in
particular, by prices.
Average Group occupancy rate1 improved vs.
H1 2023 to 85.3% (up 2.6 points). Occupancy rate for nursing homes
in France increased to 83.1% in Q2 2024, up 0.5 point vs. Q2
2023
- A sharp increase in occupancy rates outside France (up between
3.1 and 4.5 points) compared with H1 2023.
- Occupancy rate for nursing homes in France remains below
expectations, despite a favourable trend observed at the end of the
first half of this year.
H1 2024 EBITDAR at the H1 2023 level,
between €330 million and €340 million
- A 30% recovery in EBITDAR outside France, with all geographical
areas making a contribution.
- EBITDAR impacted in France by an increase in the resources
committed to facilities, which could not be offset by the rise in
occupancy rates in nursing homes.
2024 EBITDAR growth outlook revised
downwards
- emeis revises its 2024 EBITDAR growth range to between 0% and
+5% vs. FY2023, i.e. a level of between €700m and €730m (compared
with €800m to €835m previously communicated).
- The latest forecast incorporates the effect of an action plan
launched in France in the second half aimed at restoring balance
between the level of activity and resources to take account of the
lag in occupancy rate forecasts.
Cumulative disposals of real estate assets
since mid-2022 estimated at around €670 million at end-2024,
compared with the initial trajectory of €750 million
- In a still unfavourable real estate context, emeis estimates
that around €670 million in gross proceeds from real estate
disposals should be realised by the end of 2024 (reference period
starting mid 2022). This amount is to be compared with the year-end
2024 initial trajectory of €750 million which is part of its
commitment of €1,250 million to be completed by the end of 2025.
This delay is mainly due to the deferral of one specific real
estate transaction in France to 2025.
- Gross proceeds from property disposals over 2024 would be
around €380m (around €340m net of tax), compared with the €500m
(€449m net of tax) communicated in the Group's Business Plan.
Disposals of operating assets
- As indicated in the Refoundation Plan, and in addition to the
disposals of operating activities already underway outside Europe,
more significant disposals of operating assets (including the sale
of operations) could be envisaged, which would lead to an
improvement in the Group's cash position between late 2024 and
early 2025.
The emeis Group's consolidated revenue amounted to €2,772
million in the first half of 2024, an increase of 9.2%, including
mainly organic growth of 8.9%. This increase was driven by a
2.6-point increase in the Group's average occupancy rate over the
period, the effect of price increases and the positive impact of
the contribution from the opening of new facilities.
All the Group's geographical areas contributed to the strong
growth momentum in the first half of the year.
Average occupancy rate rises sharply between first-half 2023
and first-half 2024.
1. Second-quarter 2024
revenue
Revenue for the second quarter of 2024 totalled €1,397 million,
with organic growth of 8.3%. Reported growth of 7.1% includes the
impact of site closures in all Group geographical areas.
The overall trend for the second quarter of 2024 was in line
with that of the first quarter, with solid growth in revenue
underpinned by a significant increase in the Group's occupancy rate
(including a 0.5-point increase in the scope of nursing homes in
France), the ramp-up of facilities opened in the last 12 months,
and the effect of price increases.
2. First-half 2024
revenue
Revenue in all geographical areas grew sharply in the first half
of 2024, driven by positive price and care allowance effects
(approx. 5.5% on average at Group level) and, internationally, by a
marked recovery in occupancy rates and the opening of new
facilities. The price effect is mainly due to price increases,
particularly outside France, in an inflationary environment that
has impacted the main operating expense line items since 2022.
- Key highlights by geographical
area
In France, revenue rose by 4.0% to €1,183 million. This
increase was mainly due to price increases and, to a lesser extent,
to higher occupancy rates in clinics (post-acute and rehabilitation
clinics and mental health clinics) and nursing homes at the end of
the half-year. This trend did not fully offset inflation and the
level of care allowances.
The occupancy rate for France as a whole was slightly up on
first-half 2023, at 85.8%, with a level above 92% for clinics and a
slight increase for nursing homes (83.1% on average over the first
half of 2024, i.e., +0.1 point), which began mainly at the end of
the half-year.
Revenue for Southern Europe and Latam (Spain, Italy,
Portugal and Latin America) totalled €211 million, with organic
growth of 13.2%. Reported growth, including the closure of certain
facilities in Spain, Portugal and Latin America, came to 11.8%.
The average occupancy rate across the area rose sharply over the
period, to 87.8% (up 4.5 points). Spain, the area's main
contributor, saw strong momentum driven by a marked improvement in
its occupancy rate, back to a level close to what it was before the
Covid-19 crisis (up 6.5 points vs. first-half 2023, at 91.6%).
Revenue for Northern Europe (Germany, Belgium, the
Netherlands, Luxembourg) totalled €796 million, up 14.6%, including
11.9% organic growth. This strong organic growth was driven by
4.2-point increase in the average occupancy rate, significant price
revisions and the opening of new facilities, mainly in the
Netherlands. The difference between organic and reported growth
reflects the inclusion in the scope of consolidation of operations
in Belgium and the Netherlands in the second quarter of 2023.
Revenue in Eastern Europe (Austria, Switzerland, Czech
Republic, Slovenia and Croatia) also grew sharply (up 11.1% as
reported, up 11.3% on an organic basis), amounting to €472 million.
The area's two main contributors, Austria and Switzerland,
benefited from a combination of higher occupancy rates and major
price revisions. The area’s occupancy rate rose by 3.1 points over
the period.
The Other geographies (Ireland, Poland, United Kingdom,
China and United Arab Emirates) posted revenue of €110 million, up
16.7%, lifted by robust momentum in Poland and Ireland, which are
the area's two main contributors.
3. Estimated financial indicators to 30
June 2024 (unaudited figures)
In this press release, the Group comments not only on aggregates
taken from its consolidated financial statements, but also on
alternative performance indicators, whose definitions and
calculation methods are presented in full on page 7 of this press
release.
As part of this periodic publication, the Company wishes to
provide additional information on its estimated operating
performance and debt position at 30 June 2024.
Regarding operating performance, the information
available to the Company to date points to an estimated EBITDAR of
between €330 million and €340 million for the first half of 2024,
compared with €336 million for the first half of 2023.
This near stability in EBITDAR levels between H1 2023 and H1
2024 breaks down into an increase in operations outside France of
around €45 million between these two periods, offset by a reduction
in EBITDAR for operations in France of the same order of
magnitude.
The situation in the Group's operations in France is due to the
slow recovery in occupancy rates, which has not kept pace with the
increase in resources mobilised. Based on projected occupancy
rates, the Company implemented an action plan in the second half of
the year aimed at bringing resources into line with activity
levels, while guaranteeing a staffing level above average sector
standards. Backed by a growing rate of satisfaction and a
recognised medical and care project, the implementation of a
proactive commercial strategy remains a priority of this action
plan.
Net debt at 30 June 2024 stood at €4,470 million
(excluding IFRS adjustments), including cash flow of €653 million.
These levels remain close to the 2024 trajectory initially
forecast, thanks to the precautionary measures implemented to
manage capital expenditure.
Approximately €160 million in gross proceeds from the disposal
of real estate assets have been realised and around €245 million of
new real estate disposals have been signed over the first half of
2024.
The Company had an undrawn line of credit of €400 million at 30
June 2024 maturing in June 2026.
4. 2024 outlook
The estimated operating performance for first-half 2024,
combined with the various internal reviews carried out, have led
the Company to revise its 2024 EBITDAR forecast. Most of this
revision stems from the Group's operations in France, where it
turns out that the operational recovery that will take longer than
initially anticipated.
EBITDAR for 2024 is expected to increase by between 0% and 5%
compared with 2023, giving a figure of between €700 and €730
million, compared with between €800 and €835 million as previously
communicated.
On this basis, pre-IFRS 16 2024 EBITDA would be around €210
million.
In a still unfavourable real estate context, emeis estimates
that around €670 million in gross proceeds from real estate
disposals should be completed by end-2024, compared with the
initial planned trajectory of €750 million which is part of the
commitment of €1,250 million in disposals to be carried out by
end-2025 (reference period starting mid 2022). This delay is
essentially due to the postponement to 2025 of one transaction in
France initially planned for the end of 2024. Gross proceeds from
property disposals over 2024 would amount to around €380 million
(around €340 million net of tax), compared with the €500 million
(€449 million net of tax) disclosed in the Group's Business
Plan.
In order to reduce the impact of these revisions on the Group's
cash flow trajectory, emeis has taken significant additional
precautionary measures with regard to its investments. Furthermore,
as indicated in the Refoundation Plan, and in addition to the
disposals of operating activities already underway outside Europe,
more significant disposals of operating assets (including the sale
of operations) could be envisaged, which would improve the Group's
cash position between late 2024 and early 2025.
5. Planned update to the multi-year
business plan
As announced in its 17 April 2024 press release, the Group has
begun updating its multi-year business plan. At the end of this
process, which is expected to be completed by the end of the fourth
quarter of 2024, the Company will disclose, in accordance with
applicable regulations, any changes in the trajectory set out in
the business plan in the documentation relating to the recent
capital increases, in particular concerning the Group’s financial
leverage2 (as a reminder, the financial leverage included in the
business plan underlying the capital increases was 5.5x by
2026).
6. Financial information and
calendar
On 4 October 2024, the Company will present its consolidated
results for the six months ended 30 June 2024.
DISCLAIMER
This document contains forward-looking statements that involve
risks and uncertainties, including information incorporated by
reference, regarding the Group’s expected growth and profitability
in the future that may significantly impact the expected
performance indicated in the forward-looking statements. These
risks and uncertainties relate to factors that the Company cannot
control or accurately estimate, such as future market conditions.
Any forward-looking statements made in this document express
expectations for the future and should be regarded as such. Actual
events or results may differ from those described in this document
due to a number of risks or uncertainties described in Chapter 2 of
the Company’s 2023 Universal Registration Document, which is
available on the Company's website and on the website of the French
financial markets authority, AMF (www.amf-france.org).
About emeis
With nearly 78,000 experts and professionals in healthcare,
care, and supporting the most vulnerable among us, emeis operates
in around 20 countries with five core activities: psychiatric
clinics, post-acute and rehabilitation clinics, nursing homes, home
care services, and assisted-living facilities.
Every year, emeis welcomes 283,000 residents, patients, and
other beneficiaries. emeis is committed and is taking action to
rise to a major challenge facing our society, i.e., the increase in
the number of people placed in vulnerable positions as a result of
accidents or old age, and the rising number of cases of mental
illness.
emeis is 50.2% owned by Caisse des Dépôts, CNP Assurances, MAIF,
and MACSF Épargne Retraite. It is listed on the Euronext Paris
stock exchange (ISIN: FR001400NLM4) and is a member of the SBF 120
and CAC Mid 60 indices.
Website: www.emeis.com/en
1 The average Group occupancy rate published includes nursing
homes, clinics and assisted living facilities. 2 Net debt excl.
IFRS 16 lease liabilities/pre-IFRS 16 EBITDA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240726471228/en/
Press
Isabelle Herrier-Naufle Director of Press Relations &
e-Reputation +33 7 70 29 53 74 isabelle.herrier@emeis.com
IMAGE 7 Charlotte Le Barbier // Laurence Heilbronn
+33 6 78 37 27 60 // +33 6 89 87 61 37 clebarbier@image7.fr //
lheilbronn@image7.fr
Investor Relations
Benoit Lesieur Investor Relations Director
benoit.lesieur@emeis.com
Toll-free number for shareholders (from France only) 0
805 480 480
NEWCAP Dusan Oresansky +33 1 44 71 94 94
emeis@newcap.eu
Grafico Azioni Emeis (EU:EMEIS)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Emeis (EU:EMEIS)
Storico
Da Nov 2023 a Nov 2024
